|
rs1800562
|
|
|
0.900 |
GeneticVariation |
BEFREE |
A woman who inherited C282Y also possessed HLA-A3, -B7 which is considered part of the ancestral haplotype containing the gene predisposing to hemochromatosis in Caucasians.
|
11763282 |
2001 |
|
rs1800562
|
|
|
0.900 |
GeneticVariation |
BEFREE |
Serum samples were collected in 26 iron-overloaded (homozygous C282Y mutation) and 35 iron-depleted hemochromatosis patients and 33 healthy control subjects.
|
18684194 |
2008 |
|
rs1800562
|
|
|
0.900 |
GeneticVariation |
BEFREE |
We studied 214 patients with hemochromatosis who were homozygous for the C282Y substitution in HFE and had undergone liver biopsy prior to phlebotomy.
|
16344062 |
2005 |
|
rs1800562
|
|
|
0.900 |
GeneticVariation |
BEFREE |
In the third study (2002), 371 C282Y-homozygous relatives of patients with HFE-associated hemochromatosis were assessed.
|
12957297 |
2003 |
|
rs1800562
|
|
|
0.900 |
GeneticVariation |
BEFREE |
Celtic origin of the C282Y mutation of hemochromatosis.
|
10953956 |
2000 |
|
rs1800562
|
|
|
0.900 |
GeneticVariation |
BEFREE |
The presence of the C282Y HFE mutation was determined in all subjects and H63D in C282Y heterozygotes.
|
18566337 |
2008 |
|
rs1800562
|
|
|
0.900 |
GeneticVariation |
BEFREE |
HFE-associated hemochromatosis (HH) defined as homozygosity for the C282Y (n = 14, 7.2%) mutation or compound heterozygosity for the C282Y/H63D (n = 11, 5.6%) mutation was identified in 12.8% of patients.
|
16083706 |
2005 |
|
rs1800562
|
|
|
0.900 |
GeneticVariation |
BEFREE |
Unlike these rare instances, in white people, homozygotes for C282Y polymorphism in HFE are numerous, but they are only predisposed to hemochromatosis; complete organ disease develops in a minority, when these individuals abuse alcohol or from other unidentified modifying factors.
|
20542038 |
2010 |
|
rs1800562
|
|
|
0.900 |
GeneticVariation |
BEFREE |
We have examined transferrin receptor-1, ferroportin, ceruloplasmin, ferritin light and heavy chains, iron regulatory proteins (IRP)-1 and -2, and hepcidin for mutations that might modulate the iron burden of individuals harboring the common mutant hemochromatosis HFE genotype C282Y/C282Y or cause hemochromatosis independent of mutations in the HFE gene.
|
11783942 |
2003 |
|
rs1800562
|
|
|
0.900 |
GeneticVariation |
BEFREE |
Mutations in HAMP and HJV genes and their impact on expression of clinical hemochromatosis in a cohort of 100 Spanish patients homozygous for the C282Y mutation of HFE gene.
|
19214511 |
2009 |
|
rs1800562
|
|
|
0.900 |
GeneticVariation |
BEFREE |
Thus, the present patient's only intact HFE protein is C282Y, and this may explain his hemochromatosis phenotype.
|
15324319 |
2004 |
|
rs1800562
|
|
|
0.900 |
GeneticVariation |
BEFREE |
To date, only homozygosity for the C282Y mutation is considered as a diagnostic criterion of hemochromatosis.
|
9858853 |
1999 |
|
rs1800562
|
|
|
0.900 |
GeneticVariation |
BEFREE |
The low prevalence of the C282Y mutation of the HFE gene in Japan means that the genetic background of hemochromatosis in Japanese patients remains unclear.
|
15749661 |
2005 |
|
rs1800562
|
|
|
0.900 |
GeneticVariation |
BEFREE |
Population screening for hemochromatosis: a comparison of unbound iron-binding capacity, transferrin saturation, and C282Y genotyping in 5,211 voluntary blood donors.
|
10796893 |
2000 |
|
rs1800562
|
|
|
0.900 |
GeneticVariation |
BEFREE |
Screening for hemochromatosis in apparently healthy subjects homozygous for the C282Y mutation with or without a family history reveals comparable levels of hepatic iron overload and disease.
|
16476869 |
2006 |
|
rs1800562
|
|
|
0.900 |
GeneticVariation |
BEFREE |
Although a significantly lower percentage of Canadian participants than U.S. participants indicated at least one negative emotional response to the genetic testing, greater than 50% of C282Y homozygote participants (the gene mutation most strongly associated with hemochromatosis) from both countries experienced such in response to testing.
|
17394393 |
2007 |
|
rs1800562
|
|
|
0.900 |
GeneticVariation |
BEFREE |
In addition, female metastatic brain tumor patients with C282Y have shorter survival times post diagnosis than WT patients (p = 0.02) or male metastatic brain tumor patients with C282Y (p = 0.02).
|
25491948 |
2015 |
|
rs1800562
|
|
|
0.900 |
GeneticVariation |
BEFREE |
Stratification analysis by HFE mutation type revealed that the H63D mutation was associated with a significantly higher SVR rate (OR = 1.60, 95% CI: 1.09-2.34, P = 0.020), while the C282Y mutation was not (OR = 1.19, 95% CI: 0.71-1.98, P = 0.510).
|
22499121 |
2012 |
|
rs1800562
|
|
|
0.900 |
GeneticVariation |
BEFREE |
The allelic frequencies of the HFE mutations (0.017 for C282Y mutation and 0.124 for H63D mutation) did not differ between patients with CRI and healthy controls.
|
16138214 |
2005 |
|
rs1800562
|
|
|
0.900 |
GeneticVariation |
BEFREE |
Nonexpressing homozygotes for C282Y hemochromatosis: minority or majority of cases?
|
11001800 |
2000 |
|
rs1800562
|
|
|
0.900 |
GeneticVariation |
BEFREE |
Eight of 240 CVID or IgGSD index patients had hemochromatosis phenotypes and C282Y homozygosity (3 vs 0.7% and 0.2% controls; P < 0.0001, respectively).
|
12850493 |
2004 |
|
rs1800562
|
|
|
0.900 |
GeneticVariation |
BEFREE |
Using a multi-ethnic sample of cases and controls from Houston, TX, we examined two HFE variants (rs1800562 and rs1799945), one transferrin receptor gene (TFRC) variant (rs3817672) and three additional iron regulatory gene (IRG) variants (SLC11A2 rs422982; TMPRSS6 rs855791 and rs733655) for their associations with childhood ALL.
|
25085015 |
2014 |
|
rs1800562
|
|
|
0.900 |
GeneticVariation |
BEFREE |
An Irish/Belgian female with an elevated serum ferritin level and a family history of hemochromatosis was tested for the presence of the C282Y and H63D mutations.
|
11531973 |
2001 |
|
rs1800562
|
|
|
0.900 |
GeneticVariation |
BEFREE |
Patients with C282Y HFE hemochromatosis also have inappropriately low hepcidin levels for the degree of iron loading.
|
15486069 |
2005 |
|
rs1800562
|
|
|
0.900 |
GeneticVariation |
BEFREE |
The Hemochromatosis and Iron Overload Screening study screened 101 168 participants in primary care from 5 field centers in the United States and Canada with serum ferritin, transferrin saturation, and HFE genotyping for C282Y and H63D mutations.
|
20031565 |
2009 |